$181.7M in SYK Stock Sold in Two Days by Ronda Stryker After Earnings Guidance

Alex Rivera

Form 4 filings show Ronda E. Stryker sold about $181.7M of Stryker shares on February 4-5, 2026, following the company's latest earnings and guidance cycle.

Ronda E. Stryker disclosed a heavy two-day sell window in SYK: roughly $181.7M sold across February 4-5, 2026 (about 500,000 shares total).

Transaction Breakdown

DateActionSharesEstimated Value
2026-02-04S in SYK250,000~$90.73M
2026-02-05S in SYK250,000~$90.99M

The size is large, but the pattern is staged execution over adjacent sessions, which often points to programmatic liquidity management instead of a one-shot panic exit.

External Context: Post-Earnings Setup

Stryker's investor release for fourth-quarter and full-year 2025 results emphasized continued sales growth and 2026 planning. MedTech coverage also focused on procedure and segment momentum rather than a demand collapse backdrop.

Sources: Stryker investor release, MedTech Dive.

Institutional Holder Backdrop

SYK remains widely held by large institutions including Vanguard, BlackRock, State Street, JPMorgan, Banque Transatlantique SA, and Rehmann Capital Advisory Group.

Key Facts

InsiderRonda E. Stryker
TickerSYK
Sell window2026-02-04 to 2026-02-05
Total sold shares (window)500,000
Total estimated value~$181.7M

What to Watch

Explore all research